SAB Biotherapeutics, Inc. (SABS)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SABS
See up to 3 months of SABS. The 7-day demo opens the 1M and 3M ranges and puts SABS on your watchlist.
Start 7-day demoLatest SABS insider trades
About SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc. is an SEC registrant, filing under CIK 0001833214, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
SABS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 1 | 473 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SABS insider transactions (Form 4)
3629 Form 4 filings on record, the earliest from Nov 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Alexandra Kropotova - Officer | Tax withholding / forfeiture | Common Stock | 473 footnote F1 | - footnote F1 | - | |
| ||||||
| Alexandra Kropotova - Officer | Tax withholding / forfeiture | Common Stock | 988 footnote F1 | - footnote F1 | - | |
| ||||||
| Alexandra Kropotova - Officer | Tax withholding / forfeiture | Common Stock | 988 footnote F1 | - footnote F1 | - | |
| ||||||
| Eddie Joe Sullivan - Officer | Grant or award | Stock option (right to buy) | 3,000,000 footnote F1 | $0.00 | - | |
| ||||||
 Samuel J. Reich - Officer | Grant or award | Stock option (right to buy) | 4,800,000 footnote F1 | $0.00 | - | |
| ||||||
| Christoph Lawrence Bausch - Officer | Grant or award | Stock option (right to buy) | 1,800,000 footnote F1 | $0.00 | - | |
| ||||||
| Alexandra Kropotova - Officer | Grant or award | Stock option (right to buy) | 2,400,000 footnote F1 | $0.00 | - | |
| ||||||
| Lucy To - Officer | Grant or award | Stock option (right to buy) | 2,400,000 footnote F1 | $0.00 | - | |
| ||||||
 Rita Jain | Grant or award | Stock Option (right to buy) | 240,000 | $0.00 | - | |
 David Zaccardelli | Grant or award | Stock Option (right to buy) | 240,000 | $0.00 | - | |
| Jay S. Skyler | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| William James Polvino | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Erick Lucera | Grant or award | Stock option (right to buy) | 150,000 | $0.00 | - | |
| Helen K. Ellias | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Scott Giberson | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| David Link | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Alexandra Kropotova - Officer | Tax withholding / forfeiture | Common Stock | 988 footnote F1 | - footnote F1 | - | |
| ||||||
| Andrew Moin | Option exercise | Common Stock | 1,740,000 | $1.75 | $3.04M | |
| Andrew Moin | Option exercise | Series B Convertible Preferred Stock | 17,400 | - | - | |
| Sessa Capital (Master), L.P. - Director | Option exercise | Common Stock | 1,740,000 | $1.75 | $3.04M | |
| Sessa Capital (Master), L.P. - Director | Option exercise | Series B Convertible Preferred Stock | 17,400 | - | - | |
| Alexandra Kropotova - Officer | Tax withholding / forfeiture | Common Stock | 1,977 | - | - | |
| Lucy To - Officer | Grant or award | Stock Option (right to buy) | 1,200,000 | $0.00 | - | |
| Christoph Lawrence Bausch - Officer | Grant or award | Stock Option (right to buy) | 600,000 | $0.00 | - | |
| Eddie Joe Sullivan - Officer | Grant or award | Stock Option (right to buy) | 3,000,000 | $0.00 | - | |
| Alexandra Kropotova - Officer | Grant or award | Stock Option (right to buy) | 2,400,000 | $0.00 | - | |
| Samuel J. Reich - Officer | Grant or award | Stock Option (right to buy) | 4,800,000 | $0.00 | - | |
| Andrew Moin | Grant or award | Series B Convertible Preferred Stock | 228,500 | - | - | |
| Andrew Moin | Grant or award | Warrants (right to buy) | 228,500 | - | - | |
| Andrew Moin | Grant or award | Warrants (right to buy) | 114,250 | - | - | |
| Sessa Capital (Master), L.P. - Director | Grant or award | Series B Convertible Preferred Stock | 228,500 | - | - | |
| Sessa Capital (Master), L.P. - Director | Grant or award | Warrants (right to buy) | 228,500 | - | - | |
| Sessa Capital (Master), L.P. - Director | Grant or award | Warrants (right to buy) | 114,250 | - | - | |
| Alexandra Kropotova - Officer | Tax withholding / forfeiture | Common Stock | 9,072 | - | - | |
| Helen K. Ellias | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Helen K. Ellias | Grant or award | Stock Option (right to buy) | 35,000 | $0.00 | - | |
Item 8.01, 9.01
Item 7.01, 9.01
Item 5.07
Item 1.01, 9.01
SABS insider trading FAQ
What is the latest insider trade for SABS?
SAB Biotherapeutics, Inc. (SABS) had 1 insider filing in the last 90 days, with the most recent on 2026-09-18. The full record for SABS runs to 29 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SABS stock?
No insider purchases of SABS were filed in the last 90 days.
How many insiders are selling SABS stock?
No insider sales of SABS were filed in the last 90 days.
Where can I see SABS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SABS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Alexandra Kropotova view on EDGAR
- - Alexandra Kropotova view on EDGAR
- - Alexandra Kropotova view on EDGAR
- - Eddie Joe Sullivan view on EDGAR
- - Samuel J. Reich view on EDGAR
- - Christoph Lawrence Bausch view on EDGAR
- - Alexandra Kropotova view on EDGAR
- - Lucy To view on EDGAR
- - Rita Jain view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SABS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SABS with a 7-day demo
- SABS on your watchlist
- Every SABS Form 4 filing on record
- Up to 3 months of SABS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
